Fibrinolysis

Factor XIII Control?

From “Kaarin,” We are wondering what other labs are using for a positive (deficient) control for factor XIII assay by the clot-lysis methodology. Deficient plasma? Hello, Kaarin, thanks for your question, which will attract some responses soon. A quick check of major plasma control distributors shows that only Hyphen BioMed, distributed in North America by Aniara, […]

FDP and D-dimer

A question for discussion. Is there any clinical reason to test for both fibrin degradation products [FDPs] and D-dimer?

Isolated Chronically Elevated D-dimer: Reprise

Fritsma Factor continues to receive questions from individuals who report continuing elevated D-dimer concentration reports in the absence of thrombotic disease. I refer us to my recent post, Isolated Chronically Elevated D-dimer, which provides the explanations for this finding.

Isolated Chronically Elevated D-dimer

I [Geo] have had a number of questions from people who report a chronically elevated D-dimer with no clinical associations or parallel positive laboratory assays. In many cases their original D-dimer was ordered in response to a clinical indication such as chest pain or possible C19 symptoms, and remained elevated long after the original event […]

Coagulation Overview

In response to requests, we’ve posted our latest audio PowerPoint module, “Coagulation Overview.” Please visit our growing list of recently produced free modules under the menu heading, Educational Modules.

Coagulation Factors

D-dimer and DOACs

Here is a recent question from a colleague. “Dear George, A patient with a PE of unknown etiology, is now completing their 6th month of Eliquis therapy. When is the ideal time to check a D-dimer? Thank you.” Before answering, I [Geo] consulted with Dr. Larry Brace, who responds, “My opinion is that if the […]

Anticoagulant Therapy

Covid-Coag Controversies 10-18-20 Video

Click here to watch George Fritsma’s 50-minute presentation, COVID-Coag; Controversies and Confusion. This is a follow-up to our September 15 presentation featuring Dr. Andrew Goodwin, and was provided as part of the Imtermountain States Seminar annual meeting in virtual format. Special thanks to Holly Weinberg for her invitation and for coordinating the event.

Sept, 2020 Quick Question Reponse: Fibrinolysis

Here are our responses to the September, 2020 Quick Question, wich attracted 51 participants. How does your facility measure fibrinolysis? Plasminogen: 3 [5%] Tissue plasminogen activator [TPA]: 1 [2%] Plasminogen activator inhibitor 1 [PAI-1]: 1 [2%] Thromboelastograph [TEG]: 10 [20%] Rotational thromboelastometry [ROTEM]: 36 [71%] As we speculated the first three measures of fibrinolysis are […]

D-dimer Reporting

Hemostasis laboratory directors are aware of the problems created by the variety of D-dimer result expressions. D-dimer reagent kit manufacturers have failed to harmonize results, in part because their reagent monoclonal antibodies possess variant specificities, and in part because some report results in “D-dimer units” [DDUs] and some in “fibrinogen equivalent units” [FEUs]. FEU values […]

Sept, 2020 Quick Question: Fibrinolysis

Introducing our September, 2020 Quick Question, a laboratory service poll, “How do you measure fibrinolysis?” Please select your answer on the right or if you don’t see the answer you are looking for, please add your comment below.

Load more

George Fritsma is a medical laboratory scientist, educator, and author. George is a member of the International Society on Thrombosis and Hemostasis, the International Society for Laboratory Hematology, and the American Society for Clinical Laboratory Science.

Cheat Sheets from George

Quick Question